Skip Navigation



Annals of Oncology Advance Access published online on May 3, 2006
Annals of Oncology, doi:10.1093/annonc/mdl074
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
17/11/1620    most recent
mdl074v3
mdl074v2
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Massard, C.
Right arrow Articles by Soria, J.-C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Massard, C.
Right arrow Articles by Soria, J.-C.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2006 European Society for Medical Oncology
Received February 22, 2006
Accepted March 7, 2006

review

Tumour stem cell-targeted treatment: elimination or differentiation

C. Massard 1, E. Deutsch 2, and J.-C. Soria 1 *

1 Department of Medicine, Institut Gustave Roussy, Villejuif, France
2 Department of Radiation Oncology, Institut Gustave Roussy, Villejuif, France

* To whom correspondence should be addressed.
J.-C. Soria, E-mail: soria{at}igr.fr


  Abstract
This article was published by mistake on 6th April 2006. It is under embargo until 29 September 2006 and will not be available until then.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
M. Mimeault and S. K. Batra
Interplay of distinct growth factors during epithelial mesenchymal transition of cancer progenitor cells and molecular targeting as novel cancer therapies
Ann. Onc., October 1, 2007; 18(10): 1605 - 1619.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.